U.S. markets open in 4 hours 5 minutes

F S&P 500
5,304.25
+8.75(+0.17%)
F Dow Jones
38,764.00
-27.00(-0.07%)
F Nasdaq
18,669.25
+78.25(+0.42%)
E-mini Russell 2000 Index Futur
2,094.50
+18.70(+0.90%)
Petróleo
77.08
+0.09(+0.12%)
Oro
2,347.40
+1.60(+0.07%)

60 Degrees Pharmaceuticals, Inc. (SXTP)

NasdaqCM - NasdaqCM Precio en tiempo real. Divisa en USD.

Añadir a la lista de seguimiento

0.2920

+0.0022

(+0.76%)

Al cierre: 04:00PM EDT

0.2722

-0.02

(-6.78%)

Antes de la apertura del mercado:

05:14AM EDT

Transacciones de miembros de la gerencia

Divisa en USD

Compras de miembros de la gerencia en los últimos 6 meses	Acciones	Trans
Compras	0	0
Ventas	N/D	0
Acciones netas compradas (vendidas)	0	0
Acciones totales pertenecientes a miembros de la gerencia	2.71M	N/D
Acciones netas compradas (vendidas) en %	N/D	N/D

Compras institucionales netas del trimestre anterior al último	Acciones
Acciones netas compradas (vendidas)	N/D
Cambio en acciones institucionales propias en %	N/D

Miembro de la gerencia	Transacción	Tipo	Valor	Fecha	Acciones
ALLEN CHARLES W Director		Directo		16 may 2024	4,000
DOW GEOFFREY S Chief Executive Officer	Conversion of Exercise of derivative security at price 0.22 - 0.27 per share.	Directo	21,933	16 may 2024	85,000
MILLER TYRONE Chief Financial Officer	Stock Award(Grant) at price 0.22 - 0.27 per share.	Directo	19,353	16 may 2024	75,000
FIELD PAUL Director	Conversion of Exercise of derivative security at price 0.22 per share.	Directo	892	16 may 2024	4,000
XU CHERYL Director	Conversion of Exercise of derivative security at price 0.22 per share.	Directo	446	16 may 2024	2,000
TOOVEY STEPHEN Director	Stock Award(Grant) at price 0.22 per share.	Directo	892	16 may 2024	4,000
TOOVEY STEPHEN Director	Conversion of Exercise of derivative security at price 0.22 per share.	Directo	892	16 may 2024	4,000
MILLER TYRONE Chief Financial Officer	Conversion of Exercise of derivative security at price 0.26 per share.	Directo	15,804	12 abr 2024	60,000
XU CHERYL Director		Directo		01 feb 2024	2,000
DOW GEOFFREY S Chief Executive Officer	Purchase at price 0.28 per share.	Directo	7,283	31 ene 2024	25,974
XU CHERYL Director	Purchase at price 0.28 per share.	Directo	56,080	31 ene 2024	200,000
KNIGHT THERAPEUTICS, INC. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 4.75 per share.	Indirecto	216,182	28 jul 2023	45,560